title: Tissue Doppler is a more reliable method in early detection of cardiac dysfunction in patients with AA amyloidosis.
abstract: OBJECTIVE
  Cardiac deposition of AA amyloidosis may result in increasing left ventricular mass and systolic and diastolic dysfunction (DD). The aim of this study was to investigate the left ventricular systolic and diastolic functions by both tissue Doppler imaging (TDI) and pulsed wave Doppler echocardiography (PWD) in patients with AA amyloidosis without congestive heart failure symptoms or arrthymia.
  
  
  RESULTS
  Twenty-four patients with AA amyloidosis without congestive heart failure symptoms or arrthymia (15 men and nine women; mean age 44.3 +/- 16.7 years) and 25 healthy subjects (19 men and six women; mean age 43.1 +/- 9.2 years) as controls were included in the study. M-mode, two-dimensional, PWD, and TDI were performed. Peak transmitral filling velocity (E wave), peak transmitral atrial filling velocity (A wave), deceleration time, and isovolumic relaxation time were measured by PWD recordings. Peak myocardial systolic velocity (Sm), peak myocardial early (Em), and late diastolic velocities (Am) were also recorded by TDI. E/A ratio less than one was accepted as DD for both methods. Ejection fraction (EF) was calculated by Teicholtz method. The subjects were divided into three groups as follows: healthy controls (group 1), patients without DD (group 2), and patients with DD (group 3) according to the PWD findings. PWD echocardiography showed that DD was present in 50% of the patients, whereas TDI showed DD in 66% of such cases. In subgroup analysis, Sm wave as a systolic function index was lower in group 3 than in groups 1 and 2, whereas mean EF values were similar in all groups.
  
  
  CONCLUSIONS
  Although AA amyloidosis uncommonly causes cardiac symptoms and findings, according to our results, patients with AA amyloidosis may have systolic and diastolic dysfunction eventhough they are asymptomatic. Also, tissue Doppler imaging is a more reliable method in the early detection of cardiac dysfunction in such patients.
authors.affiliation: Department of Cardiology, School of Medicine, Qukurova University, Adana, Turkey.
authors.forename: Mesut
authors.initials: M
authors.lastname: Demir
authors.forename: Saime
authors.initials: S
authors.lastname: Paydaş
authors.forename: Murat
authors.initials: M
authors.lastname: Cayli
authors.forename: Onur
authors.initials: O
authors.lastname: Akpinar
authors.forename: Mustafa
authors.initials: M
authors.lastname: Balal
authors.forename: Esmeray
authors.initials: E
authors.lastname: Acartürk
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis*; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging* / Q000209:etiology / Q000503:physiopathology; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D015150:Echocardiography, Doppler / Q000379:methods; D018619:Echocardiography, Doppler, Pulsed; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D011336:Probability; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index